ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-11S4402
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antibody Market Research Report 2021
BUY CHAPTERS

Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-11S4402
Report
March 2024
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Merck
Novartis
AbbVie
Amgen Inc
Pfizer Inc
Bayer
Lilly
Bristol–Myers Squibb
GlaxoSmithKline PLC
Biogen
Astrazeneca plc
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Johnson and Johnson

Antibody - Market Size

The global market for Antibody was estimated to be worth US$ 9091 million in 2023 and is forecast to a readjusted size of US$ 13110 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Antibody - Market

Antibody - Market

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibody, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antibody by region & country, by Type, and by Application.
The Antibody market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody.
Market Segmentation

Scope of Antibody - Market Report

Report Metric Details
Report Name Antibody - Market
Forecasted market size in 2030 US$ 13110 million
CAGR 5.3%
Forecasted years 2024 - 2030
Segment by Type:
  • IgM
  • IgG
  • IgA
  • Other
Segment by Application
  • Therapeutic
  • Research
  • Diagnostic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Johnson and Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Antibody in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Antibody - Market size in 2030?

Ans: The Antibody - Market size in 2030 will be US$ 13110 million.

What is the market share of major companies in Antibody - Market?

Ans: Global top five players hold a share about 35%.

What is the Antibody - Market share by type?

Ans: In terms of product, IgG is the largest segment, with a share about 80%.

Who are the main players in the Antibody - Market report?

Ans: The main players in the Antibody - Market are Roche, Johnson and Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics

What are the Application segmentation covered in the Antibody - Market report?

Ans: The Applications covered in the Antibody - Market report are Therapeutic, Research, Diagnostic

What are the Type segmentation covered in the Antibody - Market report?

Ans: The Types covered in the Antibody - Market report are IgM, IgG, IgA, Other

1 Market Overview
1.1 Antibody Product Introduction
1.2 Global Antibody Market Size Forecast
1.2.1 Global Antibody Sales Value (2019-2030)
1.2.2 Global Antibody Sales Volume (2019-2030)
1.2.3 Global Antibody Sales Price (2019-2030)
1.3 Antibody Market Trends & Drivers
1.3.1 Antibody Industry Trends
1.3.2 Antibody Market Drivers & Opportunity
1.3.3 Antibody Market Challenges
1.3.4 Antibody Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antibody Players Revenue Ranking (2023)
2.2 Global Antibody Revenue by Company (2019-2024)
2.3 Global Antibody Players Sales Volume Ranking (2023)
2.4 Global Antibody Sales Volume by Company Players (2019-2024)
2.5 Global Antibody Average Price by Company (2019-2024)
2.6 Key Manufacturers Antibody Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Antibody Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antibody
2.9 Antibody Market Competitive Analysis
2.9.1 Antibody Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Antibody Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 IgM
3.1.2 IgG
3.1.3 IgA
3.1.4 Other
3.2 Global Antibody Sales Value by Type
3.2.1 Global Antibody Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antibody Sales Value, by Type (2019-2030)
3.2.3 Global Antibody Sales Value, by Type (%) (2019-2030)
3.3 Global Antibody Sales Volume by Type
3.3.1 Global Antibody Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Antibody Sales Volume, by Type (2019-2030)
3.3.3 Global Antibody Sales Volume, by Type (%) (2019-2030)
3.4 Global Antibody Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Therapeutic
4.1.2 Research
4.1.3 Diagnostic
4.2 Global Antibody Sales Value by Application
4.2.1 Global Antibody Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antibody Sales Value, by Application (2019-2030)
4.2.3 Global Antibody Sales Value, by Application (%) (2019-2030)
4.3 Global Antibody Sales Volume by Application
4.3.1 Global Antibody Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Antibody Sales Volume, by Application (2019-2030)
4.3.3 Global Antibody Sales Volume, by Application (%) (2019-2030)
4.4 Global Antibody Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Antibody Sales Value by Region
5.1.1 Global Antibody Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antibody Sales Value by Region (2019-2024)
5.1.3 Global Antibody Sales Value by Region (2025-2030)
5.1.4 Global Antibody Sales Value by Region (%), (2019-2030)
5.2 Global Antibody Sales Volume by Region
5.2.1 Global Antibody Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Antibody Sales Volume by Region (2019-2024)
5.2.3 Global Antibody Sales Volume by Region (2025-2030)
5.2.4 Global Antibody Sales Volume by Region (%), (2019-2030)
5.3 Global Antibody Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Antibody Sales Value, 2019-2030
5.4.2 North America Antibody Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Antibody Sales Value, 2019-2030
5.5.2 Europe Antibody Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Antibody Sales Value, 2019-2030
5.6.2 Asia Pacific Antibody Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Antibody Sales Value, 2019-2030
5.7.2 South America Antibody Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antibody Sales Value, 2019-2030
5.8.2 Middle East & Africa Antibody Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antibody Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antibody Sales Value
6.2.1 Key Countries/Regions Antibody Sales Value, 2019-2030
6.2.2 Key Countries/Regions Antibody Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Antibody Sales Value, 2019-2030
6.3.2 United States Antibody Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antibody Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antibody Sales Value, 2019-2030
6.4.2 Europe Antibody Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antibody Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antibody Sales Value, 2019-2030
6.5.2 China Antibody Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antibody Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antibody Sales Value, 2019-2030
6.6.2 Japan Antibody Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antibody Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antibody Sales Value, 2019-2030
6.7.2 South Korea Antibody Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antibody Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antibody Sales Value, 2019-2030
6.8.2 Southeast Asia Antibody Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antibody Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antibody Sales Value, 2019-2030
6.9.2 India Antibody Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antibody Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Antibody Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Antibody Product Offerings
7.1.5 Roche Recent Development
7.2 Johnson and Johnson
7.2.1 Johnson and Johnson Company Information
7.2.2 Johnson and Johnson Introduction and Business Overview
7.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Johnson and Johnson Antibody Product Offerings
7.2.5 Johnson and Johnson Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Antibody Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Antibody Product Offerings
7.3.5 Merck Recent Development
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Introduction and Business Overview
7.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Novartis Antibody Product Offerings
7.4.5 Novartis Recent Development
7.5 AbbVie
7.5.1 AbbVie Company Information
7.5.2 AbbVie Introduction and Business Overview
7.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2019-2024)
7.5.4 AbbVie Antibody Product Offerings
7.5.5 AbbVie Recent Development
7.6 Amgen
7.6.1 Amgen Company Information
7.6.2 Amgen Introduction and Business Overview
7.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Amgen Antibody Product Offerings
7.6.5 Amgen Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Introduction and Business Overview
7.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pfizer Antibody Product Offerings
7.7.5 Pfizer Recent Development
7.8 Bayer
7.8.1 Bayer Company Information
7.8.2 Bayer Introduction and Business Overview
7.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bayer Antibody Product Offerings
7.8.5 Bayer Recent Development
7.9 Lilly
7.9.1 Lilly Company Information
7.9.2 Lilly Introduction and Business Overview
7.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Lilly Antibody Product Offerings
7.9.5 Lilly Recent Development
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Company Information
7.10.2 Bristol-Myers Squibb Introduction and Business Overview
7.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Bristol-Myers Squibb Antibody Product Offerings
7.10.5 Bristol-Myers Squibb Recent Development
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Information
7.11.2 GlaxoSmithKline Introduction and Business Overview
7.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2019-2024)
7.11.4 GlaxoSmithKline Antibody Product Offerings
7.11.5 GlaxoSmithKline Recent Development
7.12 Biogen
7.12.1 Biogen Company Information
7.12.2 Biogen Introduction and Business Overview
7.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Biogen Antibody Product Offerings
7.12.5 Biogen Recent Development
7.13 AstraZeneca
7.13.1 AstraZeneca Company Information
7.13.2 AstraZeneca Introduction and Business Overview
7.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2019-2024)
7.13.4 AstraZeneca Antibody Product Offerings
7.13.5 AstraZeneca Recent Development
7.14 Sanofi
7.14.1 Sanofi Company Information
7.14.2 Sanofi Introduction and Business Overview
7.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sanofi Antibody Product Offerings
7.14.5 Sanofi Recent Development
7.15 Alexion Pharmaceuticals
7.15.1 Alexion Pharmaceuticals Company Information
7.15.2 Alexion Pharmaceuticals Introduction and Business Overview
7.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Alexion Pharmaceuticals Antibody Product Offerings
7.15.5 Alexion Pharmaceuticals Recent Development
7.16 Seattle Genetics
7.16.1 Seattle Genetics Company Information
7.16.2 Seattle Genetics Introduction and Business Overview
7.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Seattle Genetics Antibody Product Offerings
7.16.5 Seattle Genetics Recent Development
8 Industry Chain Analysis
8.1 Antibody Industrial Chain
8.2 Antibody Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antibody Sales Model
8.5.2 Sales Channel
8.5.3 Antibody Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Roche
Merck
Novartis
AbbVie
Amgen Inc
Pfizer Inc
Bayer
Lilly
Bristol–Myers Squibb
GlaxoSmithKline PLC
Biogen
Astrazeneca plc
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Johnson and Johnson
List of Tables
    Table 1. Antibody Market Trends
    Table 2. Antibody Market Drivers & Opportunity
    Table 3. Antibody Market Challenges
    Table 4. Antibody Market Restraints
    Table 5. Global Antibody Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Antibody Revenue Market Share by Company (2019-2024)
    Table 7. Global Antibody Sales Volume by Company (2019-2024) & (KG)
    Table 8. Global Antibody Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Antibody Price by Company (2019-2024) & (USD/KG)
    Table 10. Key Manufacturers Antibody Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Antibody Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Antibody
    Table 13. Global Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Antibody Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Antibody Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Antibody Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Antibody Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Antibody Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Antibody Sales Volume by Type: 2019 VS 2023 VS 2030 (KG)
    Table 22. Global Antibody Sales Volume by Type (2019-2024) & (KG)
    Table 23. Global Antibody Sales Volume by Type (2025-2030) & (KG)
    Table 24. Global Antibody Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Antibody Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Antibody Price by Type (2019-2024) & (USD/KG)
    Table 27. Global Antibody Price by Type (2025-2030) & (USD/KG)
    Table 28. Global Antibody Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Antibody Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Antibody Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Antibody Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Antibody Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Antibody Sales Volume by Application: 2019 VS 2023 VS 2030 (KG)
    Table 34. Global Antibody Sales Volume by Application (2019-2024) & (KG)
    Table 35. Global Antibody Sales Volume by Application (2025-2030) & (KG)
    Table 36. Global Antibody Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Antibody Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Antibody Price by Application (2019-2024) & (USD/KG)
    Table 39. Global Antibody Price by Application (2025-2030) & (USD/KG)
    Table 40. Global Antibody Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Antibody Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Antibody Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Antibody Sales Value by Region (2019-2024) & (%)
    Table 44. Global Antibody Sales Value by Region (2025-2030) & (%)
    Table 45. Global Antibody Sales Volume by Region (KG): 2019 VS 2023 VS 2030
    Table 46. Global Antibody Sales Volume by Region (2019-2024) & (KG)
    Table 47. Global Antibody Sales Volume by Region (2025-2030) & (KG)
    Table 48. Global Antibody Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Antibody Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Antibody Average Price by Region (2019-2024) & (USD/KG)
    Table 51. Global Antibody Average Price by Region (2025-2030) & (USD/KG)
    Table 52. Key Countries/Regions Antibody Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Antibody Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Antibody Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Antibody Sales Volume, (2019-2024) & (KG)
    Table 56. Key Countries/Regions Antibody Sales Volume, (2025-2030) & (KG)
    Table 57. Roche Company Information
    Table 58. Roche Introduction and Business Overview
    Table 59. Roche Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 60. Roche Antibody Product Offerings
    Table 61. Roche Recent Development
    Table 62. Johnson and Johnson Company Information
    Table 63. Johnson and Johnson Introduction and Business Overview
    Table 64. Johnson and Johnson Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 65. Johnson and Johnson Antibody Product Offerings
    Table 66. Johnson and Johnson Recent Development
    Table 67. Merck Company Information
    Table 68. Merck Introduction and Business Overview
    Table 69. Merck Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 70. Merck Antibody Product Offerings
    Table 71. Merck Recent Development
    Table 72. Novartis Company Information
    Table 73. Novartis Introduction and Business Overview
    Table 74. Novartis Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 75. Novartis Antibody Product Offerings
    Table 76. Novartis Recent Development
    Table 77. AbbVie Company Information
    Table 78. AbbVie Introduction and Business Overview
    Table 79. AbbVie Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 80. AbbVie Antibody Product Offerings
    Table 81. AbbVie Recent Development
    Table 82. Amgen Company Information
    Table 83. Amgen Introduction and Business Overview
    Table 84. Amgen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 85. Amgen Antibody Product Offerings
    Table 86. Amgen Recent Development
    Table 87. Pfizer Company Information
    Table 88. Pfizer Introduction and Business Overview
    Table 89. Pfizer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 90. Pfizer Antibody Product Offerings
    Table 91. Pfizer Recent Development
    Table 92. Bayer Company Information
    Table 93. Bayer Introduction and Business Overview
    Table 94. Bayer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 95. Bayer Antibody Product Offerings
    Table 96. Bayer Recent Development
    Table 97. Lilly Company Information
    Table 98. Lilly Introduction and Business Overview
    Table 99. Lilly Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 100. Lilly Antibody Product Offerings
    Table 101. Lilly Recent Development
    Table 102. Bristol-Myers Squibb Company Information
    Table 103. Bristol-Myers Squibb Introduction and Business Overview
    Table 104. Bristol-Myers Squibb Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 105. Bristol-Myers Squibb Antibody Product Offerings
    Table 106. Bristol-Myers Squibb Recent Development
    Table 107. GlaxoSmithKline Company Information
    Table 108. GlaxoSmithKline Introduction and Business Overview
    Table 109. GlaxoSmithKline Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 110. GlaxoSmithKline Antibody Product Offerings
    Table 111. GlaxoSmithKline Recent Development
    Table 112. Biogen Company Information
    Table 113. Biogen Introduction and Business Overview
    Table 114. Biogen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 115. Biogen Antibody Product Offerings
    Table 116. Biogen Recent Development
    Table 117. AstraZeneca Company Information
    Table 118. AstraZeneca Introduction and Business Overview
    Table 119. AstraZeneca Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 120. AstraZeneca Antibody Product Offerings
    Table 121. AstraZeneca Recent Development
    Table 122. Sanofi Company Information
    Table 123. Sanofi Introduction and Business Overview
    Table 124. Sanofi Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 125. Sanofi Antibody Product Offerings
    Table 126. Sanofi Recent Development
    Table 127. Alexion Pharmaceuticals Company Information
    Table 128. Alexion Pharmaceuticals Introduction and Business Overview
    Table 129. Alexion Pharmaceuticals Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 130. Alexion Pharmaceuticals Antibody Product Offerings
    Table 131. Alexion Pharmaceuticals Recent Development
    Table 132. Seattle Genetics Company Information
    Table 133. Seattle Genetics Introduction and Business Overview
    Table 134. Seattle Genetics Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
    Table 135. Seattle Genetics Antibody Product Offerings
    Table 136. Seattle Genetics Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Antibody Downstream Customers
    Table 140. Antibody Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antibody Product Picture
    Figure 2. Global Antibody Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Antibody Sales Volume (2019-2030) & (KG)
    Figure 5. Global Antibody Sales Price (2019-2030) & (USD/KG)
    Figure 6. Antibody Report Years Considered
    Figure 7. Global Antibody Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Antibody Players Sales Volume Ranking (2023) & (KG)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Revenue in 2023
    Figure 10. Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. IgM Picture
    Figure 12. IgG Picture
    Figure 13. IgA Picture
    Figure 14. Other Picture
    Figure 15. Global Antibody Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Antibody Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Antibody Sales Volume by Type (2019 VS 2023 VS 2030) & (KG)
    Figure 18. Global Antibody Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Antibody Price by Type (2019-2030) & (USD/KG)
    Figure 20. Product Picture of Therapeutic
    Figure 21. Product Picture of Research
    Figure 22. Product Picture of Diagnostic
    Figure 23. Global Antibody Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Antibody Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Antibody Sales Volume by Application (2019 VS 2023 VS 2030) & (KG)
    Figure 26. Global Antibody Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Antibody Price by Application (2019-2030) & (USD/KG)
    Figure 28. North America Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Antibody Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Antibody Sales Volume (%), (2019-2030)
    Figure 40. United States Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 61. Antibody Industrial Chain
    Figure 62. Antibody Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions